rs147641617
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_004646.4(NPHS1):c.1747G>A(p.Glu583Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHS1 | NM_004646.4 | c.1747G>A | p.Glu583Lys | missense_variant | 13/29 | ENST00000378910.10 | NP_004637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.1747G>A | p.Glu583Lys | missense_variant | 13/29 | 1 | NM_004646.4 | ENSP00000368190.4 | ||
NPHS1 | ENST00000353632.6 | c.1747G>A | p.Glu583Lys | missense_variant | 13/28 | 5 | ENSP00000343634.5 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000124 AC: 31AN: 249710Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135148
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461468Hom.: 0 Cov.: 34 AF XY: 0.0000495 AC XY: 36AN XY: 727000
GnomAD4 genome AF: 0.000538 AC: 82AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74512
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Sep 29, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 16, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at